Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.

scientific article

Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.PHRS.2016.07.006
P698PubMed publication ID27394168

P50authorRaymond M. SchiffelersQ39472386
Riccardo VagoQ55712274
P2093author name stringSander A A Kooijmans
Natasa Zarovni
P2860cites workMicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancerQ29614237
Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumorQ36043818
P921main subjectextracellular vesicleQ21097485
P304page(s)487-500
P577publication date2016-07-06
P1433published inPharmacological ResearchQ15724622
P1476titleModulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment
P478volume111

Reverse relations

cites work (P2860)
Q91811850Advances on Non-Genetic Cell Membrane Engineering for Biomedical Applications
Q44298061Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies
Q91899409Circulating miRNome detection analysis reveals 537 miRNAS in plasma, 625 in extracellular vesicles and a discriminant plasma signature of 19 miRNAs in children with retinoblastoma from which 14 are also detected in corresponding primary tumors
Q46311969Engineering of extracellular vesicles as drug delivery vehicles
Q64104933Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency
Q59792870Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo
Q64389196Exosome-packaged miR-1246 contributes to bystander DNA damage by targeting LIG4
Q92798173Exosomes as Therapeutic Vehicles for Cancer
Q61812111Exosomes: A Promising Avenue for the Diagnosis of Breast Cancer
Q64086552Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
Q89739035Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo
Q92924422Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Renal Diseases
Q90459409Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives
Q64097130Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy
Q41918293Plant Ribosome-Inactivating Proteins: Progesses, Challenges and Biotechnological Applications (and a Few Digressions).
Q99238314Recent Advances in the Use of Exosomes in Sjögren's Syndrome
Q89976335Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications
Q91828311Review of the Application of Nanovesicles and the Human Interstitial Fluid in Gastrointestinal Premalignant Lesion Detection, Diagnosis, Prognosis and Therapy
Q33899251Secretome of in vitro cultured human embryos contains extracellular vesicles that are uptaken by the maternal side.
Q90721850Stem Cell-Derived Extracellular Vesicles and Kidney Regeneration
Q64103462Stem Cell-Derived Extracellular Vesicles as Immunomodulatory Therapeutics
Q28075450Towards Therapeutic Delivery of Extracellular Vesicles: Strategies for In Vivo Tracking and Biodistribution Analysis
Q99720308Tumor-derived microparticles in tumor immunology and immunotherapy